Sunesis Pharmaceuticals competitors

Sunesis Pharmaceuticals's competitors include BerGenBio , MolMed, Innocare and FLX Bio

Add company...

Save Comparison Clear all	Sunesis Pharmaceuticals Sunesis Pharmaceuticals is focused on the R&D of oncology therapeutics for the treatment of solid and hematologic cancers.	BerGenBio BerGenBio is an oncology biotech company that develops medicines to treat cancer.	MolMed MolMed is a biotechnology company focused on research, development and clinical validation of novel antitumour therapies.	Innocare InnoCare is a biopharmaceutical company aimed to discover and develop novel treatment for cancer and autoimmune diseases.	FLX Bio FLX Bio is a biopharmaceutical company focused on the discovery, development and commercialization of novel immuno-oncology agents.
Founding Date	Founding Date 1987	Founding Date 2008	Founding Date 1996	Founding Date N/A	Founding Date 2015
Type	Type Public	Type Public	Type Public	Type Private	Type Subsidiary
Tags	Tags Healthcare biotech oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development oncology pharma therapy
Locations	Locations South San Francisco, US HQ	Locations Bergen, NO HQ	Locations Milano, IT HQ	Locations Haidian, CN HQ Pudong Xinqu, CN Nanjing, CN	Locations South San Francisco, US HQ
Employees	Employees 37	Employees 35	Employees 186	Employees 6	Employees N/A
Valuation ($)	Valuation ($) 74.4 m	Valuation ($) N/A	Valuation ($) 12.8 b	Valuation ($) N/A	Valuation ($) N/A
Funding
Total funding raised	Total funding raised $ 58.5m	Total funding raised $ 78.2m	Total funding raised N/A	Total funding raised $ 55m	Total funding raised $ 139m